Title : FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.

Pub. Date : 2002 Oct

PMID : 12602460






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The main aim of the FOSIDIAL study is to assess the efficacy and safety of fosinopril, an angiotensin converting enzyme (ACE) inhibitor, in reducing the mortality and cardiovascular events in haemodialysis patients presenting with left ventricular hypertrophy. Fosinopril angiotensin I converting enzyme Homo sapiens
2 The main aim of the FOSIDIAL study is to assess the efficacy and safety of fosinopril, an angiotensin converting enzyme (ACE) inhibitor, in reducing the mortality and cardiovascular events in haemodialysis patients presenting with left ventricular hypertrophy. Fosinopril angiotensin I converting enzyme Homo sapiens